These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37332241)

  • 1. The clinical application value of salivary pepsin in the diagnosis of gastroesophageal reflux diseases.
    Chen R; Shi L; Huang X; Mao H; Feng B; Wang M; Lin L; Jiang L
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14627. PubMed ID: 37332241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva pepsin measurements in the detection of gastroesophageal reflux disease in laryngopharyngeal reflux patients: a cohort study.
    Lechien JR; Bobin F
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3765-3771. PubMed ID: 37140740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.
    Dy F; Amirault J; Mitchell PD; Rosen R
    J Pediatr; 2016 Oct; 177():53-58. PubMed ID: 27453366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold level of Peptest in diagnosing gastroesophageal reflux disease with extraesophageal symptoms: Evidence from Vietnam.
    Nguyen LT; Le TD; Hoang LB; Vu VT; Nguyen TD; Luu HTM; Do PN; Van Nguyen A; Van Dao L; Larsson M; Olson L; Dao HV
    JGH Open; 2023 Dec; 7(12):916-922. PubMed ID: 38162841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of the Peptest
    Zeleník K; Hránková V; Vrtková A; Staníková L; Komínek P; Formánek M
    J Clin Med; 2021 Jul; 10(13):. PubMed ID: 34279479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease and salivary pepsin in patients with heterotopic gastric mucosa in the upper esophagus.
    Xiong X; He S; Xu F; Xu Z; Zhang X; Wang H; Liu T; Jia Y
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34750620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic thresholds and optimal collection protocol of salivary pepsin for gastroesophageal reflux disease.
    Ma SD; Patel VG; Greytak M; Rubin JE; Kaizer AM; Yadlapati RH
    Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36148576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.
    Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR
    Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
    Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes.
    Zhang M; Wu T; Tan N; Chen S; Zhuang Q; Luo Y; Xiao Y
    Gastroenterol Rep (Oxf); 2023; 11():goad053. PubMed ID: 37720194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.
    Race C; Chowdry J; Russell JM; Corfe BM; Riley SA
    Aliment Pharmacol Ther; 2019 May; 49(9):1173-1180. PubMed ID: 30977177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients.
    Fortunato JE; D'Agostino RB; Lively MO
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27604397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multichannel intraluminal impedance-pH monitoring and reflux scintigraphy in pediatric patients with suspected gastroesophageal reflux.
    Uslu Kızılkan N; Bozkurt MF; Saltık Temizel IN; Demir H; Yüce A; Caner B; Özen H
    World J Gastroenterol; 2016 Nov; 22(43):9595-9603. PubMed ID: 27920480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis.
    Guo Z; Jiang J; Wu H; Zhu J; Zhang S; Zhang C
    Medicine (Baltimore); 2021 Aug; 100(32):e26756. PubMed ID: 34397878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease.
    Yadlapati R; Kaizer A; Greytak M; Ezekewe E; Simon V; Wani S
    Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 33180095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.